Gleason prostate grade 2-4 (low)
Related entities
Findings (50)
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
declineRelated PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo
Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83
None
nullPre-donation mental health status (MCS score), depression, and anxiety levels were not significantly associated with donation-associated pain and toxicities at any time point post-donation in related
Effect: null
None
nullPre-donation mental health status (MCS score), depression, and anxiety levels were not significantly associated with donation-associated pain and toxicities at any time point post-donation in related
Effect: null
None
nullPre-donation mental health status (MCS score), depression, and anxiety levels were not significantly associated with donation-associated pain and toxicities at any time point post-donation in related
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null
None
nullNeither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.
Effect: null